Identifying and treating amiodarone-induced corneal deposits: When the heart saves and the cornea speaks

Table 2 Practical clinical approach to ocular complaints in patients receiving amiodarone

Clinical scenario	Suggested approach	Clinical rationale
Asymptomatic cornea verticillata identified during routine examination	Reassure the patient, document the finding, and continue ophthalmic follow-up as clinically indicated	Cornea verticillata is a frequent and generally benign finding and, in isolation, does not usually warrant discontinuation of amiodarone[1,13]
Mild visual symptoms in the presence of typical cornea verticillata and no concerning features	Evaluate the ocular surface and other potentially modifiable factors; offer symptom-directed treatment and appropriate follow-up	Symptoms are not always explained by epithelial deposits alone and may reflect concurrent ocular surface disease or reduced optical quality[15,26-39]
Persistent or clinically meaningful visual complaints	Arrange ophthalmologic assessment if the patient is not already under specialist care; perform slit-lamp examination, visual acuity testing, and targeted ancillary investigations when appropriate	A structured ophthalmic evaluation can help distinguish typical amiodarone keratopathy from other coexisting or alternative causes of symptoms[9-13,17,30,40]
Visual loss that appears disproportionate to the corneal findings	Perform prompt comprehensive ophthalmologic evaluation, including posterior segment examination and neuro-ophthalmic assessment	Visual loss that exceeds what would be expected from cornea verticillata should not be attributed to corneal deposits alone without further evaluation[25,45-47]
Red flags, including optic disc swelling, afferent pupillary defect, dyschromatopsia, visual field defects, progressive bilateral visual decline, or neuro-ophthalmic symptoms	Urgent specialist evaluation together with timely discussion with the treating cardiologist	These findings raise concern for amiodarone-associated optic neuropathy or another serious cause of visual dysfunction[25,45-47]
Consideration of amiodarone dose reduction, withdrawal, or replacement	Do not base this decision on cornea verticillata alone; consider treatment modification only after multidisciplinary discussion, particularly when symptoms are severe, progressive, unexplained, or when optic neuropathy is suspected	Amiodarone is often clinically indispensable from a cardiologic standpoint, so ocular findings need to be interpreted within the broader systemic context[1,13,25,45-47]